Oxygen-Exacerbated Bleomycin Pulmonary Toxicity

Mayo Clinic Proceedings

Volumn 66, Issue 2, 1991, Pages 173-178

  INGRASSIA, THEODORE S ^a   RYU, JAY H ^a   TRASTEK, VICTOR F ^b   ROSENOW, EDWARD C ^a  

^a Division of Thoracic Diseases and Internal Medicine ^*

^b Section of General Thoracic Surgery ^*

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; OXYGEN;

ADULT; ARTICLE; BREATHING DISORDER; CASE REPORT; CORTICOSTEROID THERAPY; EMBRYONAL CARCINOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CARCINOMA; MALE; PRIORITY JOURNAL; TERATOCARCINOMA;

EID: 0026086698     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(12)60489-3     Document Type: Article

References (33)

1. New antibiotics, bleomycin A and B
2. A clinical review of bleomycin—a new antineoplastic agent
3. Drug-induced pulmonary disease. Part 1. Cytotoxic drugs
4. Reduction of pulmonary toxicity
5. Large-dose bleomycin therapy and pulmonary toxicity: a possible role of prior radiotherapy
6. Pulmonary toxicity after radiation and bleomycin: a review
7. Factors influencing postoperative morbidity and mortality in patients treated with bleomycin
8. Reactivation of bleomycin lung toxicity following oxygen administration
9. Bleomycin pneumonitis potentiated by oxygen administration
10. Potentiation of bleomycin-induced lung injury by exposure to 70% oxygen
11. Modification of oxygen toxicity after lung injury by bleomycin in hamsters
12. Differences in effects of immediate and delayed hyperoxia exposure on bleomycin-induced pulmonary injury
13. Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats
14. Bleomycin and subsequent anaesthesia: a retrospective study at Vancouver General Hospital
15. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction
16. Mechanism of bleomycin action: in vitro studies
17. Differential protective effects of varying degrees of hypoxia on the cytotoxicities of etoposide and bleomycin
18. The biochemical and molecular bases of bleomycin-induced pulmonary fibrosis
19. Modifications of the effect of bleomycin in the somatic mutation and recombination test in Drosophila melanogaster
20. Inhibition of the genotoxicity of bleomycin by superoxide dismutase
21. Modifiers of free radicals inhibit in vitro the oncogenic actions of x-rays, bleomycin, and the tumor promoter 12-O-tetradecanoylphorbol 13-acetate
22. Correlation between the anti-oxidant enzyme activities of blood fractions and the yield of bleomycin-induced chromosome damage
23. Pulmonary strategies of antioxidant defense
24. Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance
25. Mechanisms of drug-induced pulmonary disease
26. Bronchoalveolar lavage cell populations in bleomycin lung toxicity
27. Early diagnosis of bleomycin pulmonary toxicity using bronchoalveolar lavage in dogs
28. A molecular basis for bleomycin-induced pulmonary fibrosis
29. Normobaric oxygen toxicity of the lung
30. Pulmonary oxygen toxicity
31. Pulmonary oxygen toxicity: a review
32. Bleomycin causes alveolar macrophages from cigarette smokers to release hydrogen peroxide
33. Bleomycin increases superoxide anion generation by pig peripheral alveolar macrophages